Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10 mg (Mitiglinide) in Type 2 Diabetes Mellitus Patients With Normal or Moderate Impaired Hepatic Function

NCT04349696 is registered in ClinicalTrials.gov with Orient Europharma Co., Ltd. as lead sponsor.

NCT NCT04349696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04349696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10 mg (Mitiglinide) in Type 2 Diabetes Mellitus Patients With Normal or Moderate Impaired Hepatic Function
Lead sponsor
Orient Europharma Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
February 11, 2014
Completion date
April 30, 2018
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver dysfunction, type 2 diabetes mellitus